Sharp Phillip A
- SEC CIK
- 0001226295
No open-market purchases or sales filed in the past year.
Current role at each company
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of Jan 24, 2025
- VIR Vir Biotechnology, Inc.Directoras of May 24, 2023
- CIK 0001556263Directoras of Jun 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sharp Phillip A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 (view filing) | Jan 23 | 1 day | Sharp Phillip ADirector | SSale | −11.3K | $275.00 | −$3.09M | −100.0%0 after | 10b5-1 |
| Mar 1, 2024 (view filing) | Feb 29 | 1 day | Sharp Phillip ADirector | SSale | −30.0K | $151.34 | −$4.54M | −100.0%0 after | 6 lots10b5-1 |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Sharp Phillip ADirector | SSale | −33.7K | $230.49 | −$7.76M | −100.0%0 after | 6 lots |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | Sharp Phillip ADirector | SSale | −30.0K | $150.00 | −$4.50M | −100.0%0 after |